Pan-Asian adaptation of ESMO renal cell carcinoma guidelines published

Guideline · UroToday · 2026-10-28. Number 4 in the UrologyWatch Top 5 for October 29, 2026.

A pan-Asian adapted version of the ESMO Clinical Practice Guidelines addresses diagnosis, treatment and follow-up for renal cell carcinoma, incorporating regional considerations.

Why it matters: Provides a regionally adapted reference for RCC management that may differ from Western guideline defaults in drug access and sequencing.

Source: UroToday · PubMed 42914499 · DOI 10.1016/j.esmoop.2026.108552

The full October 29, 2026 edition · Today's urology news